??pid??miologie de l???infection urinaire communautaire de l???adulte en France, p.1, 2007. ,
DOI : 10.1007/978-2-287-48617-3_1
Une histoire de la résistance aux antibiotiques. A propos de six bactéries, 2009. ,
Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.657-686, 2005. ,
DOI : 10.1055/s-2003-37919
Emergence of Enterobacteriaceae producing extended-spectrum ??-lactamases (ESBLs) in the community, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.52-59, 2005. ,
DOI : 10.1093/jac/dki166
The Structure of <latex>$\beta$</latex>-Lactamases, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.289, issue.1036, pp.321-331, 1980. ,
DOI : 10.1098/rstb.1980.0049
Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-317, 1983. ,
DOI : 10.1007/BF01641355
: identification of CTX-1, a novel ??-lactamase, Journal of Antimicrobial Chemotherapy, vol.20, issue.3, pp.323-334, 1987. ,
DOI : 10.1093/jac/20.3.323
Extended-spectrum beta-lactamases., Antimicrobial Agents and Chemotherapy, vol.33, issue.8, pp.1131-1136, 1989. ,
DOI : 10.1128/AAC.33.8.1131
Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14, 2004. ,
DOI : 10.1128/AAC.48.1.1-14.2004
Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-166, 2008. ,
DOI : 10.1016/S1473-3099(08)70041-0
in the Community: Lessons from the Study of a Remote and Controlled Population, The Journal of Infectious Diseases, vol.202, issue.4, pp.515-523, 2010. ,
DOI : 10.1086/654883
Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.2, pp.112-117, 2000. ,
DOI : 10.1007/s100960050440
Surveillance des bactéries multirésistantes. Résultats année, CCLIN OUEST, 2011. ,
Nationwide survey of extended-spectrum ??-lactamase-producing Enterobacteriaceae in the French community setting, Journal of Antimicrobial Chemotherapy, vol.63, issue.6, pp.1205-1214, 2009. ,
DOI : 10.1093/jac/dkp108
URL : https://hal.archives-ouvertes.fr/hal-00426312
Réseau MedQual: surveillance de l'évolution des résistances des souches d'Escherichia coli isolées en ville, 2012. ,
Animal reservoirs for extended spectrum beta-lactamase producers, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, pp.117-123, 2008. ,
The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria, The Lancet Infectious Diseases, vol.13, issue.2, pp.155-165, 2013. ,
DOI : 10.1016/S1473-3099(12)70317-1
A Multinational Survey of Risk Factors for Infection with Extended???Spectrum ?????Lactamase???Producing Enterobacteriaceae in Nonhospitalized Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.682-690, 2009. ,
DOI : 10.1086/604713
URL : https://hal.archives-ouvertes.fr/hal-00426315
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum ??-lactamases, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.780-783, 2006. ,
DOI : 10.1093/jac/dkl035
Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.3, pp.163-167, 2004. ,
DOI : 10.1007/s10096-003-1084-2
Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum ??-lactamase (ESBL) and non-ESBL Producing Escherichia coli, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.240-248, 2010. ,
DOI : 10.1016/S1684-1182(10)60038-2
Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum ??-Lactamase-Producing Escherichia coli Strains, Journal of Clinical Microbiology, vol.50, issue.2, pp.312-317, 2012. ,
DOI : 10.1128/JCM.06002-11
Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli, C. Moon, S. Y. Shin, and Korean Network for Study of Infectious Diseases (KONSID) Int. J. Antimicrob. Agents, vol.36, issue.3, pp.284-287, 2010. ,
Risk Factors Associated with the Community-Acquired Colonization of Extended-Spectrum Beta-Lactamase (ESBL) Positive Escherichia Coli. An Exploratory Case-Control Study, PLoS ONE, vol.2, issue.9, p.74323, 2013. ,
DOI : 10.1371/journal.pone.0074323.t004
Risk factors for community- and health facility???acquired extended-spectrum ??-lactamase???producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview, American Journal of Infection Control, vol.40, issue.9, pp.849-853, 2012. ,
DOI : 10.1016/j.ajic.2011.10.019
Enterobacteriaceae bacteremia: Risk factors for ESBLPE, M??decine et Maladies Infectieuses, vol.44, issue.1, 2013. ,
DOI : 10.1016/j.medmal.2013.11.003
Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study, PLoS ONE, vol.14, issue.1, p.30498, 2012. ,
DOI : 10.1371/journal.pone.0030498.t006
Plan national d'alerte sur les antibiotiques 2011- 2016, 2011. ,
Recommandations relatives aux mesures à mettre en oeuvre pour prévenir l'émergence des entérobactéries BLSE et lutter contre leur dissémination, 2010. ,
Improving the quality of antimicrobial drug use can result in cost containment, Pharmacy World & Science, vol.15, issue.6, pp.163-167, 1995. ,
DOI : 10.1007/BF01879711
Antibiogramme -Société Française de Microbiologie Recommandations 2013, 2013. ,
Alternatives to carbapenems in ESBL-producing Escherichia coli infections, M??decine et Maladies Infectieuses, vol.43, issue.2, pp.62-66, 2013. ,
DOI : 10.1016/j.medmal.2013.01.006
URL : https://hal.archives-ouvertes.fr/hal-00802661
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli ,
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates, Rev. Esp. Quimioter. Publ. Of. Soc. Esp. Quimioter, vol.26, issue.1, pp.43-46, 2005. ,
Etude rétrospective sur la prise en charge des infections urinaires à entérobactéries productrices de bêta-lactamases à spectre étendu par les médecins généralistes libéraux, 2014. ,
Argumentaires pour les recommandations faites en 2011 à propos des céphalosporines de 3e génération et l'aztréonam vis-à-vis des entérobactéries, 2011. ,
Etude des pratiques des médecins généralistes dans la prise en charge des infections uriniares à entérobactéries sécrétrices de bêta-lactamase à spectre étendu, 2013. ,
DOI : 10.1016/s0399-077x(14)70249-5
Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-448, 2008. ,
DOI : 10.1016/j.jinf.2008.09.034
Conclusions., Infection Control & Hospital Epidemiology, vol.8, issue.06, pp.534-542, 2009. ,
DOI : 10.1016/j.jhin.2008.02.003
Influx of Extended-Spectrum ??-Lactamase--Producing Enterobacteriaceae into the Hospital, Clinical Infectious Diseases, vol.42, issue.7, pp.925-934, 2006. ,
DOI : 10.1086/500936
Duration of colonization by extended-spectrum ??-lactamase-producing Enterobacteriaceae after hospital discharge, American Journal of Infection Control, vol.41, issue.5, pp.443-447, 2013. ,
DOI : 10.1016/j.ajic.2012.05.015
Duration of colonisation by Enterobacteriaceae producing extended-spectrum ??-lactamase and risk factors for persistent faecal carriage, Journal of Hospital Infection, vol.75, issue.1, pp.76-78, 2010. ,
DOI : 10.1016/j.jhin.2009.11.010
Long-term carriage of extended-spectrum betalactamase-producing Escherichia coli, " Scand, J. Infect. Dis, vol.44, issue.1, pp.51-54, 2012. ,
Avis de la Commission -Invanz 1g, poudre pour solution à diluer pour perfusion, 2003. ,
Recommandations 2014).pdf.. [53] Evolution des consommations d'antibiotiques en France entre : nouveau rapport d'analyse de l'ANSM -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé Available: http://ansm.sante.fr/S-informer/Points-d-information- Points-d-information/Evolution-des-consommations-d-antibiotiques-en-France, 2000. ,
Le Kit BLSE: un outil d'aide à la prise en charge des infections urinaires communautaires à Escherichia coli porteur d'une beta-lactamase à spectre élargi: évaluation de la procédure de diffusion, 2013. ,